XML 15 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 26, 2016
Mar. 28, 2015
Revenues:    
Net component revenues $ 5,978,134 $ 7,128,369
Research and development revenues 141,004 1,456,622
Total revenues 6,119,138 8,584,991
Expenses:    
Cost of component revenues 4,647,041 5,283,733
Research and development 4,039,951 4,860,192
Selling, general and administration 3,760,849 4,386,215
Total expenses 12,447,841 14,530,140
Loss from operations (6,328,703) (5,945,149)
Other income and expense:    
Interest income 164,948 209,664
Other income, net 37,907 19,510
Foreign currency transaction losses (551,940) (179,589)
Gain on sale of investments 0 2,142,421
Total other income and expense (349,085) 2,192,006
Loss before provision for income taxes, equity loss in unconsolidated affiliate and net income attributable to noncontrolling interest (6,677,788) (3,753,143)
Tax provision (141,000) (12,500)
Loss before equity loss in unconsolidated affiliate and net income attributable to noncontrolling interest (6,818,788) (3,765,643)
Equity loss in unconsolidated affiliate 0 (47,443)
Net loss (6,818,788) (3,813,086)
Net income attributable to the noncontrolling interest (98,673) (24,906)
Net loss attributable to the controlling interest $ (6,917,461) $ (3,837,992)
Net (loss) income per share    
Earnings Per Share, Basic $ (0.11) $ (0.06)
Earnings Per Share, Diluted $ (0.11) $ (0.06)
Weighted average number of common shares    
Weighted average common shares outstanding, basic 63,978,048 63,083,652
Weighted average common shares outstanding, diluted 63,978,048 63,083,652